Christopher SchottPartner at Latham & Watkins LLPSpeaker
Profile
Chris primarily advises on price reporting and other compliance obligations related to the Medicaid, Medicare, and 340B drug pricing programs. He combines extensive regulatory insight with deep industry knowledge to support pharmaceutical clients at all stages of the market access and product life cycle.
Agenda Sessions
Shifting Winds – Navigating the New Administration
, 11:45amView Session